The role of AMP kinase in diabetes

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 389-398

  Misra, Parimal ^a   Chakrabarti, Ranjan ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

AMP kinase; Diabetes; Thiazolidinediones

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; ADIPOCYTOKINE; CHOLESTEROL; GLUCOSE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATE; PIOGLITAZONE; PROTEIN P300; ROSIGLITAZONE; TRIACYLGLYCEROL;

AMPUTATION; BLINDNESS; CLINICAL TRIAL; DIABETES MELLITUS; DRUG TARGETING; EDEMA; ENERGY; ENZYME ACTIVATION; EXERCISE; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART MUSCLE ISCHEMIA; HUMAN; IN VIVO STUDY; INSULIN RESISTANCE; KIDNEY FAILURE; LIPID ANALYSIS; LIPID METABOLISM; METABOLIC DISORDER; MUSCLE CONTRACTION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; WEIGHT GAIN;

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADIPOCYTES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE; HUMANS; LIVER; MODELS, BIOLOGICAL;

EID: 34249313005     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Rondinone CM. Diabetes: the latest developments in inhibitors, insulin sensitisers, new drug targets and novel approaches. Expert Opin Ther Targets 2005; 9: 415-8.
2. Hardie DG, Carling D. The AMP- activated protein kinasefuel gauge of the mammalian cell? Eur J Biochem 1997; 246: 259-73.
3. Hutber CA, Hardie DG, Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol 1997; 272: E262-6.
4. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996; 270: E299-304.
5. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995; 270: 17513-20.
6. Corton JM, Gilliespie JG, Hardie DG. Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol 1994; 4: 314-24.
7. Witters LA, Nordlund AC, Marshall L. Regulation of intracellular acetyl-CoA carboxylase by ATP depletors mimics the action of the 5′-AMP-activated protein kinase. Biophys Biochem Res Commun 1991; 181: 1486-92.
8. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999; 24: 22-5.
9. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271: 611-4.
10. Stein SC, Woods A, Jones NA, Davison MD, Carting D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 2000; 345: 437-45.
11. Crute BE, Seefeld K, Gamble J, Kemp BE, Witters LA. Functional domains of the a1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 1998; 273: 35347-54.
12. Winder WW. AMP-activated protein kinase: possible target for treatment of type 2 diabetes. Diabetes Technol Ther 2000; 2: 441-8.
13. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 1987; 79: 1330-7.
14. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195-204.
15. Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action in skeletal muscle from patients with NIDDM. Mol Cell Biochem 1998; 182: 153-60.
16. Bjornholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 1997; 46: 524-7.
17. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-20.
18. Wojtaszewski JF, Hansen BF, Urso B, Richter EA. Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol 1996; 81: 1501-9.
19. Lee AD, Hansen PA, Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 1995; 361: 51-4.
20. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995; 92: 5817-21.
21. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. J Biol Chem 1995; 270: 2107-11.
22. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2001; 91: 1017-28.
23. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 1998; 47: 1369-73.
24. Bergeron R, Russell RR 3rd, Young LH, Ren JM, Marcucci M, Lee A, et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 1999; 276: E938-44.
25. 1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 2004; 279: 1070-9.
26. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum M. A role for AMP-activated protein kinase in contraction and hypoxia-regulated glucose transport in skeletal muscle. J Mol Cell 2001; 7: 1085-94.
27. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 2003; 94: 1373-9.
28. Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 2002; 282: E18-23.
29. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, et al. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 2002; 51: 2886-94.
30. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, et al. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 1997; 272: 13255-61.
31. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000; 279: E1202-6.
32. Dean D, Daugaard JR, Young ME, Saba A, Vavvas D, Asp S, et al. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 2000; 49: 1295-300.
33. Ruderman, NB, Saha AK, Vavvas D, Witters LA, Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999; 276: E1-18.
34. Davies SP, Carting D, Munday MR, Hardie DG. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Eur J Biochem 1992; 203: 615-23.
35. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995; 229: 558-65.
36. Velasco G, Geelen MJ, Guzman M. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 1997; 337: 169-75.
37. Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, et al. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 2002; 51: 2199-206.
38. Hubert A, Husson A, Chedeville A, Lavoinne A. AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes. FEBS Lett 2000; 481: 209-12.
39. Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 2000; 49: 896-903.
40. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-95.
41. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SI, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002; 99: 16309-13.
42. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003; 52: 1355-63.
43. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2002; 415: 339-43.
44. Steinberg GR, Rush JW, Dyck DJ. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am J Physiol Endocrinol Metab 2003; 284: E648-54.
45. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 2003; 100: 10207-12.
46. Watt MJ, Steinberg GR, Chan S, Garnham A, Kemp BE, Febbraio MA. Beta-adrenergic stimulation of skeletal muscle HSL can be overridden by AMPK signaling. FASEB J 2004; 18: 1445-6.
47. Yang W, Hong YH, Shen XQ, Frankowski C, Camp HS, Leff T. Regulation of transcription by AMP-activated protein kinase. J Biol Chem 2001; 276: 38341-4.
48. Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002; 277: 25226-32.
49. Musi N, Goodyear U. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 119-27.